158 related articles for article (PubMed ID: 17288609)
21. The role of the vascular endothelium in arenavirus haemorrhagic fevers.
Kunz S
Thromb Haemost; 2009 Dec; 102(6):1024-9. PubMed ID: 19967131
[TBL] [Abstract][Full Text] [Related]
22. [South American Hemorrhagic Fever viruses and the cutting edge of the vaccine and antiviral development].
Lee M; Koma T; Iwasaki M; Urata S
Uirusu; 2022; 72(1):7-18. PubMed ID: 37899233
[TBL] [Abstract][Full Text] [Related]
23. Establishment of conventional and fluorescence resonance energy transfer-based real-time PCR assays for detection of pathogenic New World arenaviruses.
Vieth S; Drosten C; Charrel R; Feldmann H; Günther S
J Clin Virol; 2005 Mar; 32(3):229-35. PubMed ID: 15722028
[TBL] [Abstract][Full Text] [Related]
24. Cell entry by human pathogenic arenaviruses.
Rojek JM; Kunz S
Cell Microbiol; 2008 Apr; 10(4):828-35. PubMed ID: 18182084
[TBL] [Abstract][Full Text] [Related]
25. Highly Pathogenic New World Arenavirus Infection Activates the Pattern Recognition Receptor Protein Kinase R without Attenuating Virus Replication in Human Cells.
Huang C; Kolokoltsova OA; Mateer EJ; Koma T; Paessler S
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794024
[TBL] [Abstract][Full Text] [Related]
26. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
27. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
Golden JW; Maes P; Kwilas SA; Ballantyne J; Hooper JW
J Virol; 2016 Jan; 90(7):3515-29. PubMed ID: 26792737
[TBL] [Abstract][Full Text] [Related]
28. [Arenavirus research and antiviral candidate].
Tani H; Shuzo U
Uirusu; 2018; 68(1):51-62. PubMed ID: 31105135
[TBL] [Abstract][Full Text] [Related]
29. Characterization of monoclonal antibodies to Junin virus nucleocapsid protein and application to the diagnosis of hemorrhagic fever caused by South American arenaviruses.
Nakauchi M; Fukushi S; Saijo M; Mizutani T; Ure AE; Romanowski V; Kurane I; Morikawa S
Clin Vaccine Immunol; 2009 Aug; 16(8):1132-8. PubMed ID: 19553554
[TBL] [Abstract][Full Text] [Related]
30. Antibody-Based Inhibition of Pathogenic New World Hemorrhagic Fever Mammarenaviruses by Steric Occlusion of the Human Transferrin Receptor 1 Apical Domain.
Ferrero S; Flores MD; Short C; Vazquez CA; Clark LE; Ziegenbein J; Zink S; Fuentes D; Payes C; Batto MV; Collazo M; García CC; Abraham J; Cordo SM; Rodriguez JA; Helguera G
J Virol; 2021 Aug; 95(17):e0186820. PubMed ID: 34132574
[TBL] [Abstract][Full Text] [Related]
31. The phylogeny of New World (Tacaribe complex) arenaviruses.
Bowen MD; Peters CJ; Nichol ST
Virology; 1996 May; 219(1):285-90. PubMed ID: 8623541
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the Innate Immune Responses to Pathogenic and Nonpathogenic Clade B New World Arenaviruses.
Moreno H; Möller R; Fedeli C; Gerold G; Kunz S
J Virol; 2019 Oct; 93(19):. PubMed ID: 31270228
[TBL] [Abstract][Full Text] [Related]
33. Combination of highly antigenic nucleoproteins to inaugurate a cross-reactive next generation vaccine candidate against Arenaviridae family.
Azim KF; Lasker T; Akter R; Hia MM; Bhuiyan OF; Hasan M; Hossain MN
Heliyon; 2021 May; 7(5):e07022. PubMed ID: 34041391
[TBL] [Abstract][Full Text] [Related]
34. Hemostasis defects underlying the hemorrhagic syndrome caused by mammarenaviruses in a cynomolgus macaque model.
Lafoux B; Baillet N; Picard C; Fourcaud G; Borges-Cardoso V; Reynard S; Journeaux A; Germain C; Perthame E; Mateo M; Hortion J; Carnec X; Pietrosemoli N; Moroso M; Lacroix O; Jourjon O; Barron S; Vallve A; Duthey A; Jacquot F; Barrot L; Dirheimer M; Raoul H; Nougier C; Baize S
Blood; 2023 Dec; 142(24):2092-2104. PubMed ID: 37699247
[TBL] [Abstract][Full Text] [Related]
35. Arenavirus extinction through lethal mutagenesis.
de la Torre JC
Virus Res; 2005 Feb; 107(2):207-14. PubMed ID: 15649566
[TBL] [Abstract][Full Text] [Related]
36. Assessing cross-reactivity of Junín virus-directed neutralizing antibodies.
Leske A; Waßmann I; Schnepel K; Shifflett K; Holzerland J; Bostedt L; Bohn P; Mettenleiter TC; Briggiler AM; Brignone J; Enria D; Cordo SM; Hoenen T; Groseth A
Antiviral Res; 2019 Mar; 163():106-116. PubMed ID: 30668977
[TBL] [Abstract][Full Text] [Related]
37. Past, present and future therapeutic and prophylactic strategies against arenaviruses responsible of human hemorrhagic fever.
Zaza AD; Herbreteau CH; Peyrefitte CN; Emonet SF
Virologie (Montrouge); 2017 Dec; 21(6):267-285. PubMed ID: 33120601
[TBL] [Abstract][Full Text] [Related]
38. The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses.
Iwasaki M; Cubitt B; Sullivan BM; de la Torre JC
J Virol; 2016 Jan; 90(6):3187-97. PubMed ID: 26739049
[TBL] [Abstract][Full Text] [Related]
39. Models for an arenavirus infection in a rodent population: consequences of horizontal, vertical and sexual transmission.
Banerjee C; Allen LJ; Salazar-Bravo J
Math Biosci Eng; 2008 Oct; 5(4):617-45. PubMed ID: 19278272
[TBL] [Abstract][Full Text] [Related]
40. Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.
Martinez-Sobrido L; de la Torre JC
Expert Rev Vaccines; 2016 Sep; 15(9):1113-21. PubMed ID: 27118328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
